Third Edition
edited by
Eric J. Topol
Acute Coronary Syndromes is abounding with figures and graphs that support key data.
Acute Coronary Syndromes, Third Edition contains 7 new chapters on topics including:
- the genomics of acute myocardial infarction
- the use of CRP, myeloperoxidase, N-tyrosine, and other disease markers
- new arterial inflammatory markers
- the enhancement of microcirculatory perfusion in the coronary bed
- the impact of diabetes and metabolic syndrome on the development of ACS
- cardiogenic shock and Killip Class III
- the use of pluripotent stem cells
- BNP and proBNPAudience
Acute Coronary Syndromes stands alone as the most comprehensive, contemporary view of the biology, physiology, and management of acute coronary syndromes (ACS)-offering 32 chapters that span the state-of-the science in the field and provide intriguing discussions on CRP and other disease markers, microcirculation, stem cell therapy, and the development of specialized centers for ACS treatment.
Contents:
- Vascular Biology of the Acute Coronary Syndromes
- Plaque Rupture: Pathological and Anatomical Considerations
- Insights from Intravascular Ultrasound
- Differences Between Unstable Angina and Acute Myocardial Infarction: The Pathophysiological and Clinical Spectrum
- Acute ST-Segment Elevation Myocardial Infarction: Current Approach and the Open Artery
- Prehospital Treatment of Acute Myocardial Infarction
- Thrombolysis for Acute Myocardial Infarction: First- and Second-Generation Agents
- Third-Generation Thrombolytic Agents for Acute Myocardial Infarction
- Diagnosis of Acute Coronary Syndromes in the Emergency Department: Evolution of Chest Pain Centers
- Primary Angioplasty in Acute Myocardial Infarction
- Myocardial Rupture
- Advances in Antiplatelet Therapy for Acute Cardiovascular Disease
- Antithrombin Therapy in Acute Coronary Syndromes
- Bedside Anticoagulant Testing
- The Role of Troponin and Other Markers for Myocardial Necrosis in Risk Stratification
- Treatment of Acute Myocardial Infarction: International and Regional Differences
- Lessons from the GUSTO Trials
- Reperfusion Injury
- Stenting for Acute Coronary Syndromes
- Plaque Stabilization and Secondary Prevention
- Quality of Coronary Disease Scorecards
Index